These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 31789394

  • 1. MicroRNA‑21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c‑Jun (AP‑1) signalling pathway.
    Fan B, Jin Y, Zhang H, Zhao R, Sun M, Sun M, Yuan X, Wang W, Wang X, Chen Z, Liu W, Yu N, Wang Q, Liu T, Li X.
    Int J Oncol; 2020 Jan; 56(1):178-192. PubMed ID: 31789394
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
    Li X, Xin S, He Z, Che X, Wang J, Xiao X, Chen J, Song X.
    Cell Physiol Biochem; 2014 Jan; 33(6):1631-42. PubMed ID: 24902663
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of lncRNA CASC2 by microRNA-21 increases the proliferation and migration of renal cell carcinoma cells.
    Cao Y, Xu R, Xu X, Zhou Y, Cui L, He X.
    Mol Med Rep; 2016 Jul; 14(1):1019-25. PubMed ID: 27222255
    [Abstract] [Full Text] [Related]

  • 4. RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma.
    Chen F, Bai J, Li W, Mei P, Liu H, Li L, Pan Z, Wu Y, Zheng J.
    PLoS One; 2013 Jul; 8(2):e56241. PubMed ID: 23457532
    [Abstract] [Full Text] [Related]

  • 5. miR‑21 attenuates contrast‑induced renal cell apoptosis by targeting PDCD4.
    Wang K, Bei WJ, Liu YH, Li HL, Chen SQ, Lin KY, Zhou ZL, Chen JY, Liu Y, Tan N.
    Mol Med Rep; 2017 Nov; 16(5):6757-6763. PubMed ID: 28901491
    [Abstract] [Full Text] [Related]

  • 6. Role of miR-21 in the growth and metastasis of human salivary adenoid cystic carcinoma.
    Yan F, Wang C, Li T, Cai W, Sun J.
    Mol Med Rep; 2018 Mar; 17(3):4237-4244. PubMed ID: 29328455
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-384 Inhibits the Growth and Invasion of Renal Cell Carcinoma Cells by Targeting Astrocyte Elevated Gene 1.
    Song H, Rao Y, Zhang G, Kong X.
    Oncol Res; 2018 Apr 10; 26(3):457-466. PubMed ID: 28877780
    [Abstract] [Full Text] [Related]

  • 8. STAT3 regulates the migration and invasion of a stem‑like subpopulation through microRNA‑21 and multiple targets in hepatocellular carcinoma.
    Zhang N, Duan WD, Leng JJ, Zhou L, Wang X, Xu YZ, Wang XD, Zhang AQ, Dong JH.
    Oncol Rep; 2015 Mar 10; 33(3):1493-8. PubMed ID: 25571964
    [Abstract] [Full Text] [Related]

  • 9. Down-Regulation of Circular RNA_000926 Attenuates Renal Cell Carcinoma Progression through miRNA-411-Dependent CDH2 Inhibition.
    Zhang D, Yang XJ, Luo QD, Fu DL, Li ZL, Zhang P, Chong T.
    Am J Pathol; 2019 Dec 10; 189(12):2469-2486. PubMed ID: 31476285
    [Abstract] [Full Text] [Related]

  • 10. Let-7d inhibits intratumoral macrophage M2 polarization and subsequent tumor angiogenesis by targeting IL-13 and IL-10.
    Su B, Han H, Gong Y, Li X, Ji C, Yao J, Yang J, Hu W, Zhao W, Li J, Zhang G, Zhou L.
    Cancer Immunol Immunother; 2021 Jun 10; 70(6):1619-1634. PubMed ID: 33237349
    [Abstract] [Full Text] [Related]

  • 11. miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma.
    Zhu Q, Wang Z, Hu Y, Li J, Li X, Zhou L, Huang Y.
    Oncol Rep; 2012 May 10; 27(5):1660-8. PubMed ID: 22322403
    [Abstract] [Full Text] [Related]

  • 12. Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma.
    Yamasaki T, Seki N, Yamada Y, Yoshino H, Hidaka H, Chiyomaru T, Nohata N, Kinoshita T, Nakagawa M, Enokida H.
    Int J Oncol; 2012 Sep 10; 41(3):805-17. PubMed ID: 22766839
    [Abstract] [Full Text] [Related]

  • 13. microRNA-21-induced dissociation of PDCD4 from rictor contributes to Akt-IKKβ-mTORC1 axis to regulate renal cancer cell invasion.
    Bera A, Das F, Ghosh-Choudhury N, Kasinath BS, Abboud HE, Choudhury GG.
    Exp Cell Res; 2014 Oct 15; 328(1):99-117. PubMed ID: 25016284
    [Abstract] [Full Text] [Related]

  • 14. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
    Hong X, Yu JJ.
    Int J Oncol; 2019 May 15; 54(5):1676-1690. PubMed ID: 30816490
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA‑218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2.
    Mu L, Guan B, Tian J, Li X, Long Q, Wang M, Wang W, She J, Li X, Wu D, Du Y.
    Oncol Rep; 2020 Nov 15; 44(5):1961-1970. PubMed ID: 32901879
    [Abstract] [Full Text] [Related]

  • 16. Rac Signaling Drives Clear Cell Renal Carcinoma Tumor Growth by Priming the Tumor Microenvironment for an Angiogenic Switch.
    Goka ET, Chaturvedi P, Lopez DTM, Lippman ME.
    Mol Cancer Ther; 2020 Jul 15; 19(7):1462-1473. PubMed ID: 32371578
    [Abstract] [Full Text] [Related]

  • 17. FBXO22 Suppresses Metastasis in Human Renal Cell Carcinoma via Inhibiting MMP-9-Mediated Migration and Invasion and VEGF-Mediated Angiogenesis.
    Guo F, Liu J, Han X, Zhang X, Lin T, Wang Y, Bai J, Han J.
    Int J Biol Sci; 2019 Jul 15; 15(3):647-656. PubMed ID: 30745851
    [Abstract] [Full Text] [Related]

  • 18. MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.
    Schanza LM, Seles M, Stotz M, Fosselteder J, Hutterer GC, Pichler M, Stiegelbauer V.
    Int J Mol Sci; 2017 Nov 22; 18(11):. PubMed ID: 29165391
    [Abstract] [Full Text] [Related]

  • 19. Circular RNA hsa_circ_0054537 sponges miR-130a-3p to promote the progression of renal cell carcinoma through regulating cMet pathway.
    Li R, Luo S, Zhang D.
    Gene; 2020 Sep 05; 754():144811. PubMed ID: 32464246
    [Abstract] [Full Text] [Related]

  • 20. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
    Hemmerlein B, Galuschka L, Putzer N, Zischkau S, Heuser M.
    Histopathology; 2004 Dec 05; 45(6):603-11. PubMed ID: 15569051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.